The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

NCT04179656 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
HER2 Gene Mutation
HER-2 Gene Amplification
HER-2 Protein Overexpression

Interventions

DRUG: Pyrotinib

Sponsor

Tianjin Medical University Second Hospital

Collaborators

[object Object]